fropenem has been researched along with Pneumococcal Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, SD; Critchley, IA; Jacobs, MR; Janjic, N; Tillotson, GS; Traczewski, MM | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Sakata, H | 1 |
| Allouch, PY; Decousser, JW; Picot, F; Pina, P | 1 |
| Akita, H; Goshima, T; Ishihara, T; Iwai, N; Iwata, S; Kanemura, H; Kato, T; Kusumoto, Y; Meguro, H; Nakamura, H; Nakashima, M; Satoh, Y; Sunakawa, K; Terashima, I; Toyonaga, Y; Yokota, T | 1 |
| Haruta, T; Kobayashi, KI; Kubota, M; Nishio, T | 1 |
1 trial(s) available for fropenem and Pneumococcal Infections
| Article | Year |
|---|---|
[Clinical evaluation of faropenem against infections in pediatric fields].
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Diarrhea; Dosage Forms; Drug Therapy, Combination; Female; Humans; Infant; Lactams; Male; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections | 1997 |
5 other study(ies) available for fropenem and Pneumococcal Infections
| Article | Year |
|---|---|
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2008 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Drug Resistance, Microbial; France; Humans; Infant; Lactams; Microbial Sensitivity Tests; Pneumococcal Infections; Sampling Studies; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
A case of retropharyngeal abscess caused by penicillin-resistant Streptococcus pneumoniae.
Topics: Abscess; Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Biopsy, Needle; Drug Therapy, Combination; Female; Humans; Infant; Lactams; Penicillin Resistance; Penicillins; Pharynx; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins | 2002 |